Strykr Analysis
BearishStrykr Pulse 38/100. Sentiment is stretched, fundamentals are weak. Threat Level 4/5. Risk is high, and the window for profit is closing fast.
If you’re looking for a case study in market amnesia, pull up a chart of the Russell Microcap Index and try not to laugh. The index is up big, headlines are breathlessly touting a 'recovery,' and yet, wait for it, 57% of its constituents lost money last year. That’s not just a red flag, it’s a full-blown parade.
This is not the first time the market has fallen for the siren song of unprofitable growth. The dot-com era had Pets.com, the SPAC bubble had electric truck prototypes that never rolled, and now, 2026’s flavor is microcaps with negative earnings and positive price action. The difference? This time, the macro backdrop is a cocktail of post-pandemic liquidity hangover, AI-driven sector churn, and a retail crowd that’s still convinced every dip is a buying opportunity.
MarketWatch’s latest piece (“Small caps’ ‘recovery’ is a myth built on unprofitable stocks. Here’s what history says happens next.”, marketwatch.com, 2026-02-25) lays out the inconvenient truth: more than half of the Russell Microcap Index is bleeding cash. Historically, when the index composition looks like this, the party doesn’t end with a gentle fade. It ends with a trapdoor.
Let’s talk numbers. The Russell Microcap Index is up nearly 18% year-to-date, outpacing the S&P 500 and even the Nasdaq. But if you strip out the handful of profitable names, the rest of the index is a graveyard of negative free cash flow and questionable business models. The last time we saw this kind of divergence between price and profit was in 2021, right before the SPAC implosion.
What’s driving the bid? Part of it is the hope trade. With the AI boom compressing software valuations and big tech looking toppy, some traders are rotating into small caps, hoping for mean reversion. But hope is not a strategy. The reality is that unprofitable companies are burning through cash faster than they can raise it. With rates still elevated and bank lending standards tight, the runway is getting shorter.
Add to that the fact that liquidity is drying up. The Fed’s balance sheet is shrinking, and there’s no sign of a rate cut on the horizon. Retail flows have slowed, and institutional desks are more interested in selling rips than buying dips. The result? A market that looks strong on the surface but is rotting underneath.
If you’re hunting for a catalyst, look no further than earnings season. As Q1 numbers start to trickle in, expect a reality check. The market can ignore fundamentals for a while, but eventually, cash flow matters. When the music stops, the exit doors will be small and crowded.
The cross-asset picture isn’t much better. Commodities are flat (DBC at $24.675, unchanged), tech is treading water (XLK at $140.18, unchanged), and global macro is a minefield of tariff wars and central bank brinkmanship. The only thing that’s moving is sentiment, and right now, it’s swinging between FOMO and fear with every headline.
Strykr Watch
Technically, the Russell Microcap Index is flirting with resistance near its 2021 highs. Momentum indicators are stretched, with RSI above 70 on the daily chart, a classic sign of overbought conditions. Volume is thinning, a warning that conviction is fading. If the index breaks below its 50-day moving average, expect a quick trip down to the 200-day. Support levels to watch: 1,250 and 1,180. Resistance: 1,320.
Breadth is deteriorating. Fewer stocks are making new highs, and the advance-decline line is rolling over. This is not the kind of setup that ends well for late longs. If you’re trading microcaps, keep stops tight and don’t chase green candles.
The options market is flashing caution. Put-call ratios are climbing, and implied volatility is ticking up. Dealers are likely short gamma, which means any downside move could accelerate as hedges are put on. Watch for a volatility spike if earnings disappoint.
On the macro side, keep an eye on liquidity flows. If the Fed signals a hawkish tilt or if credit spreads widen, microcaps will be the first to get hit. This is a market that loves risk, until it doesn’t.
The biggest risk? A liquidity shock. If one of the larger, unprofitable names blows up, it could trigger a cascade of forced selling. Remember Archegos? Microcaps are even less liquid.
The opportunity? If you’re nimble, there will be some spectacular short setups. Look for failed breakouts and fading momentum. If you’re long, consider rotating into higher-quality small caps with positive cash flow and real earnings. Avoid the lottery tickets.
Strykr Take
This is not a recovery, it’s a mirage. The market is rewarding hope over fundamentals, and history says that never ends well. If you’re trading microcaps, keep your stops tight and your exits planned. The next move is likely down, not up.
Strykr Pulse 38/100. Sentiment is stretched, fundamentals are weak. Threat Level 4/5. Risk is high, and the window for profit is closing fast.
Sources (5)
Small caps' ‘recovery' is a myth built on unprofitable stocks. Here's what history says happens next.
The Russell Microcap Index is surging — yet 57% of its members lost money last year. That never ends well.
This Is Not A Normal Rotation - It's A Regime Change
The post-pandemic market is driven by rapidly evolving macro themes, with AI now causing disruptive sector rotations and compressing software valuatio
Why this investor says you can make good money off software stocks — if you trade them like telephone directories
Deep value investor Lee Roach is looking at beaten-down software stocks for the first time ever.
Morning Bid: Another day, another AI mood swing
What matters in U.S. and global markets today
World Trade Surged in 2025, Despite Higher Tariffs
The volume of goods moving across national borders increased by 4.4% in 2025, a pickup from 2.5% in 2024, according to the Netherlands Bureau for Econ